Literature DB >> 24563275

Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy.

Farkas Sükösd1, Béla Iványi, László Pajor.   

Abstract

The current protocol for reporting urinary bladder cancer in radical cystectomies may exhibit limitations in the diagnostic accuracy, such as a risk of understaging, especially in cases with prostatic involvement. Difficulty can arise in the verification of stage pT0, and the assessment of surgical margins is suboptimal. We have developed a daily gross dissection protocol practice where radical cystectomies are totally embedded and evaluated histologically in whole-mount sections. We report here on the first 138 consecutive specimens from 2008 to the first quarter of 2012 inclusive. The incidence of the cancer stages was compared with data on 15,586 radical cystectomies from the literature. The differences were analyzed with the one-sample z-test (p < 0.05). The following emerged from and our series and the literature data: pT0 8.7 % and 6.1 %; pTa 0.7 % and 2.9 %; pTis 2.9 % and 6 %; pT1 15.2 % and 15.5 %; pT2 21 % and 23.3 %; pT3 34.8 % and 34.3 %; and pT4 16.7 % and 11 %, respectively. Our findings closely reflected the means of the published statistical data based on a large number of cases. The differences were due to the more detailed processing: the case numbers in groups from pTis to pT2 were comparatively low, while those in groups pT3 and pT4 were higher. The difference in group pT4 was significant (p = 0.0494). With this method, only those samples were regarded as pT0 in which the granulomatous area and the hemosiderin deposition indicative of the earlier intervention were observable and the entire preparation was tumor-free.

Entities:  

Mesh:

Year:  2014        PMID: 24563275     DOI: 10.1007/s12253-014-9748-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

Review 1.  Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique.

Authors:  Rodolfo Montironi; Liang Cheng; Roberta Mazzucchelli; Marina Scarpelli; Ziya Kirkali; Francesco Montorsi; Antonio Lopez-Beltran
Journal:  Eur Urol       Date:  2008-10-28       Impact factor: 20.096

2.  Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Authors:  R James Yu; John P Stein; Jie Cai; Gus Miranda; Susan Groshen; Donald G Skinner
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

3.  Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.

Authors:  Michael Rink; Behfar Ehdaie; Eugene K Cha; David A Green; Pierre I Karakiewicz; Marko Babjuk; Vitaly Margulis; Jay D Raman; Robert S Svatek; Harun Fajkovic; Richard K Lee; Giacomo Novara; Jens Hansen; Siamak Daneshmand; Yair Lotan; Wassim Kassouf; Hans-Martin Fritsche; Armin Pycha; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-02-15       Impact factor: 20.096

4.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Authors:  Stephan Madersbacher; Werner Hochreiter; Fiona Burkhard; George N Thalmann; Hansjörg Danuser; Regula Markwalder; Urs E Studer
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

5.  Bladder cancer as seen in giant histologic sections.

Authors:  E A Soto; G H Friedell; A J Tiltman
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

6.  The historical development of the staging of bladder tumors: personal reminiscences.

Authors:  H J Jewett
Journal:  Urol Surv       Date:  1977-04

Review 7.  Staging and reporting of urothelial carcinoma of the urinary bladder.

Authors:  Liang Cheng; Rodolfo Montironi; Darrell D Davidson; Antonio Lopez-Beltran
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

8.  Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.

Authors:  Derya Tilki; Oliver Reich; Pierre I Karakiewicz; Giacomo Novara; Wassim Kassouf; Süleyman Ergün; Yves Fradet; Vincenzo Ficarra; Guru Sonpavde; Christian G Stief; Eila Skinner; Robert S Svatek; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2010-01-20       Impact factor: 20.096

9.  The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.

Authors:  Edwin Herrmann; Eva Stöter; Arndt van Ophoven; Stefan Bierer; Christian Bolenz; Lothar Hertle; Christian Wülfing
Journal:  Int J Urol       Date:  2008-05-02       Impact factor: 3.369

10.  Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.

Authors:  P R van Dijk; M Ploeg; K K H Aben; P C Weijerman; H F M Karthaus; J Th H van Berkel; A C Viddeleer; A Geboers; E van Boven; J A Witjes; L A L M Kiemeney
Journal:  ISRN Urol       Date:  2011-04-27
View more
  2 in total

1.  What can be more prognostic than the pTNM category assessed on radical cystectomy specimens?

Authors:  Farkas Sükösd; Béla Iványi; László Pajor
Journal:  Virchows Arch       Date:  2015-08-23       Impact factor: 4.064

2.  In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.

Authors:  Nadine T Gaisa; Holger Wilms; Peter J Wild; Gerhard Jakse; Axel Heidenreich; Ruth Knuechel
Journal:  Virchows Arch       Date:  2015-02-13       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.